Back to top
more

Myriad Genetics Inc. (MYGN)

(Delayed Data from NSDQ)

 Add to portfolio

Trades from $3

$15.66 USD

15.66
1,541,930

+0.20 (1.29%)

Updated Jan 20, 2017 03:59 PM ET

Volume: 1,541,930

Open: $15.48

Prior Close: $15.46

5-Strong Sell         5

Value: A | Growth: D | Momentum: D | VGM: B

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for MYGN [?]:

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Myriad Genetics Inc. falls in the month of June.

All items in Millions except Per Share data.

6/30/2016 6/30/2015 6/30/2014 6/30/2013 6/30/2012
Assets          
Cash & Equivalents 159 145 186 372 341
Receivables 95 88 85 98 63
Notes Receivable 0 0 0 0 0
Inventories 38 25 24 5 12
Other Current Assets 22 26 27 9 7
Total Current Assets 315 284 322 484 422
Net Property & Equipment 58 67 35 28 24
Investments & Advances 80 41 84 159 114
Other Non-Current Assets 0 0 0 22 19
Deferred Charges 0 0 3 29 31
Intangibles 423 370 374 70 73
Deposits & Other Assets 5 5 5 13 8
Total Assets 881 766 824 804 691
Liabilities & Shareholders Equity 6/30/2016 6/30/2015 6/30/2014 6/30/2013 6/30/2012
Notes Payable 0 0 0 0 0
Accounts Payable 21 21 23 18 10
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 50 46 56 44 33
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 2 2 1 2 2
Total Current Liabilities 72 69 81 65 45
Mortgages 0 0 0 0 0
Deferred Taxes/Income 18 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 42 35 24 11 10
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 132 104 105 75 55
Shareholders Equity 6/30/2016 6/30/2015 6/30/2014 6/30/2013 6/30/2012
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 830 745 718 697 648
Retained Earnings -73 -77 2 31 -13
Other Equity -10 -7 -2 -0 -0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 748 662 719 729 636
Total Liabilities & Shareholder's Equity 881 766 824 804 691
Total Common Equity 748 662 719 729 636
Shares Outstanding 70.30 69.40 74.80 79.60 84.80
Book Value Per Share 10.64 9.54 9.61 9.15 7.50

Fiscal Year End for Myriad Genetics Inc. falls in the month of June.

All items in Millions except Per Share data.

12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015
Assets          
Cash & Equivalents NA 148 159 217 219
Receivables NA 103 95 94 89
Notes Receivable NA 0 0 0 0
Inventories NA 54 38 25 29
Other Current Assets NA 18 22 36 38
Total Current Assets NA 323 315 372 376
Net Property & Equipment NA 57 58 60 62
Investments & Advances NA 52 80 70 66
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 834 423 361 363
Deposits & Other Assets NA 5 5 5 5
Total Assets NA 1,271 881 868 872
Liabilities & Shareholders Equity 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015
Notes Payable NA 199 0 0 0
Accounts Payable NA 20 21 14 17
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 55 50 51 48
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 1 2 2 2
Total Current Liabilities NA 275 72 66 66
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 88 18 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 42 32 35
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 536 132 98 101
Shareholders Equity 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 827 830 847 848
Retained Earnings NA -87 -73 -69 -69
Other Equity NA -6 -10 -8 -9
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 735 748 770 771
Total Liabilities & Shareholder's Equity NA 1,271 881 868 872
Total Common Equity 0 735 748 770 771
Shares Outstanding 68.40 68.70 70.30 71.20 69.70
Book Value Per Share 0.00 10.70 10.64 10.82 11.06